Histological evaluation of benign prostatic hyperplasia treated by long-term administration of chlormadinone acetate (CMA)
- 1 September 1994
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 25 (3), 147-155
- https://doi.org/10.1002/pros.2990250306
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Pathology of Benign Prostatic HyperplasiaUrologic Clinics of North America, 1990
- Development of a model for the induction of estrogen-related prostatic hyperplasia in the dog and its response to the aromatase inhibitor 4-hydroxy-4-androstene-3,17-dione: Preliminary resultsThe Prostate, 1986
- The Development of Human Benign Prostatic Hyperplasia with AgeJournal of Urology, 1984
- The pathogenesis of benign prostatic hyperplasiaAmerican Journal Of Medicine, 1980
- The Dog Prostate Under Defined Hormonal Influences: An Approach to Experimental Induced Prostatic GrowthPathology - Research and Practice, 1980
- Light Microscopic Stereological Analysis of the Normal Human Prostate and of Benign Prostatic HyperplasiaJournal of Urology, 1979
- Comparison of spontaneous and experimentally induced canine prostatic hyperplasia.Journal of Clinical Investigation, 1979
- STUDIES OF MECHANISMS OF THE ACTION OF ANDROGENS ON PROSTATEThe Japanese Journal of Urology, 1972
- Medical Treatment of Benign Nodular Prostatic Hyperplasia with Cyproterone AcetateJournal of Urology, 1969
- Effects of an Anti-androgen, SH 714 (6-Chlor Δ6-l, 2α- Methylen-17α-hydroxyprogesterone Acetate, Cyproterone Acetate) on Canine Prostatic Hyperplasia1Endocrinology, 1968